Dr. Zweig has over twenty years' experience in biotechnology. He
founded Avocet Medical, Inc. in 1991, served as CEO through 1997, and
Chairman through 2001. Avocet developed the AvoSureTM home CoumadinTM
monitoring meter, which pioneered new treatments for thrombosis in the
US and Europe. Its innovative dry-reagent protease-substrate chemistry
and miniaturized fluorescent detector technology won an AAMI award in
1997, and has recently been acquired by Beckman-Coulter.
In addition to stability monitoring technology, Dr. Zweig also works and
consults in biosensors (molecular pathways), medical diagnostics
(2diabetes.com), telemedicine (controlbot.com) and bioengineering
Dr. Zweig received his Ph.D. in biochemistry from UCSD in 1980. He was
an assistant professor in pharmacology at Baylor College of Medicine,
and an Arthritis Foundation postdoctoral fellow at NIH. Dr. Zweig has
also held management positions at Bayer Diagnostics, and LifeScan, a
Johnson and Johnson company.
Dr. Zweig is an advisor to the College of Creative Studies at UCSB.